[Urinary tract infection by multiresistant Escherichia coli and Klebsiella pneumoniae: case report]

Rev Esp Quimioter. 2012 Dec;25(4):295-6.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Amoxicillin-Potassium Clavulanate Combination / pharmacology
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Bacterial Proteins / metabolism
  • Coinfection / drug therapy
  • Coinfection / microbiology*
  • Drug Resistance, Multiple, Bacterial*
  • Escherichia coli / drug effects*
  • Escherichia coli / enzymology
  • Escherichia coli / isolation & purification
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Proteins / metabolism
  • Female
  • Humans
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / microbiology*
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / enzymology
  • Klebsiella pneumoniae / isolation & purification
  • Meropenem
  • R Factors
  • Thienamycins / therapeutic use
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / microbiology*
  • beta-Lactamases / metabolism

Substances

  • Bacterial Proteins
  • Escherichia coli Proteins
  • Thienamycins
  • Amoxicillin-Potassium Clavulanate Combination
  • beta-lactamase CMY-2
  • beta-lactamase SHV-12
  • beta-Lactamases
  • Meropenem